Senna Syrup
- Product NDC
- 50268-731
- 11-digit product format
- 502680731
- Labeler code
- 50268
- Product ID
- 50268-731_47fc0bf5-eef4-b3d2-e063-6294a90a1cc9
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- AVPAK
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-05-03
- Substance
- SENNOSIDES
- Active strength
- 8.8 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Senna Syrup
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 8.8 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3FYP5M0IJX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 702311 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| af75d33f-b081-4b9d-bc12-d2829fa1f0cf | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50268-731-11 | Senna Syrup | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 7 | |
| 50268-731-24 | Senna Syrup | 24 in 1 BOX | LIQUID | 24 | 7 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50268-731-11 | ML - Milliliter | 50268-731 | b8fee383-d41d-4237-adc3-ed5c7aed8a65 | 1 | 2025-05-14 |
| 50268-731-24 | ML - Milliliter | 50268-731 | 06883b77-97ec-4fd3-8848-91482aa6050b | 1 | 2021-06-02 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| up and up fiber therapy | PSYLLIUM HUSK | TARGET CORPORATION | 956c48f8-c705-4a86-9866-c68a48ddeb6c | 2026-11-06 | Warnings | M007 |
| Sennosides | SENNOSIDES | REMEDYREPACK INC. | 3873abcd-8312-47d1-bccf-4265e1e32861 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | PSYLLIUM HUSK | Target Corporation | 674753ee-1174-4c06-9ed3-a090b338a39e | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy Natural Fiber | PSYLLIUM HUSK | Target Corporation | f8b1c831-6fd0-4a58-9726-4e0f986c8084 | 2026-11-06 | Warnings | M007 |
| up and up fiber therapy | CALCIUM POLYCARBOPHIL | Target Corporation. | e5473950-06f4-4ea4-975b-3ac94957e776 | 2026-11-06 | Warnings | M007 |
| Target Fiber Laxative | PSYLLIUM HUSK | TARGET CORPORATION | a581116a-392d-4ac3-ae15-4318506a7b2a | 2026-11-05 | Warnings | M007 |
| up and up gentle laxative | BISACODYL | Target Corporation | 4a29dc2b-b68f-471b-a84e-4a5096aa3748 | 2026-11-05 | Warnings | M007 |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | The Procter & Gamble Manufacturing Company | a9824f73-5ea2-4a65-a926-3a57561441b8 | 2026-11-04 | Warnings | M007 |
| Colon Detox | DOCUSATE SODIUM AND SENNOSIDES | OPMX LLC | 0a4d3265-080c-d2ed-e063-6394a90adbee | 2026-11-04 | Warnings | M007 |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-11-04 | Warnings | M007 |
| Fiber Caplets | CALCIUM POLYCARBOPHIL | SAFEWAY | 08e2e8b0-90b3-48d6-a72a-40688c74771a | 2026-11-03 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 9b3b6cea-ab83-4b7c-a425-fd0ac7df426c | 2026-11-02 | Warnings, Adverse reactions | M007 |
| Gentle Laxative Stimulant Laxative | BISACODYL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | bcd3c07d-bd83-4452-9736-35c85db30c15 | 2026-10-29 | Warnings | M007 |
| Quality Choice | CALCIUM POLYCARBOPHIL | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | f1e69c65-c1b0-459f-9a12-b1a92b90036b | 2026-10-29 | Warnings | M007 |
| CDMA Fiber Therapy | METHYLCELLULOSE | CHAIN DRUG MARKETING ASSOCIATION | 62bbcaf2-1d0c-485f-9159-685700aa3418 | 2026-10-29 | Warnings | M007 |
| citroma | MAGNESIUM CITRATE | Old East Main Co. | 51ed515b-cc51-4ea1-b612-090476135005 | 2026-10-29 | Warnings, Adverse reactions | M007 |
| Quality Choice Fiber Laxative | PSYLLIUM HUSK | QUALITY CHOICE (CHAIN DRUG MARKETING ASSOCIATION) | 2ee637c4-c4c6-4a24-ae99-612205afd592 | 2026-10-29 | Warnings | M007 |
| Magnesium Citrate | EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 Visions LLC | 5eeb0d66-06c7-7789-e063-6394a90aaff4 | 2026-10-28 | Warnings | M007 |
| Fiber Lax | CALCIUM POLYCARBOPHIL | PD-Rx Pharmaceuticals, Inc. | 730198a5-b6d9-4fc7-b053-a7c65a93c540 | 2026-10-27 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM AND SENNOSIDES | Marlex Pharmaceuticals Inc | 9c87759f-3856-4f30-b5ea-4b37ed90f18c | 2026-10-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | af75d33f-b081-4b9d-bc12-d2829fa1f0cf | 7 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | af75d33f-b081-4b9d-bc12-d2829fa1f0cf | 7 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | af75d33f-b081-4b9d-bc12-d2829fa1f0cf | 7 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | af75d33f-b081-4b9d-bc12-d2829fa1f0cf | 7 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | af75d33f-b081-4b9d-bc12-d2829fa1f0cf | 7 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50268-731-11 | 50268073111 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | ||||
| 50268-731-24 | 50268073124 | 24 CUP, UNIT-DOSE in 1 BOX (50268-731-24) / 5 mL in 1 CUP, UNIT-DOSE (50268-731-11) | 2021-05-03 | 0000-00-00 | No | No | Current |